Palvella Therapeutics PVLA Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $2.91M+12.4% | $2.59M+10.2% | $2.35M+23.1% | $1.91M+68.4% | $1.13M+142% | ||
| $28.1M+23.0% | $22.84M+25.1% | $18.26M+22.4% | $14.92M+32.7% | $11.24M+37.9% | ||
| $17.49M+10.9% | $15.76M+17.6% | $13.4M+15.2% | $11.63M+29.7% | $8.97M+50.8% | ||
| $45.59M+18.1% | $38.6M+21.9% | $31.66M+19.3% | $26.55M+31.4% | $20.21M+43.4% | ||
| -$45.59M-18.1% | -$38.6M-21.9% | -$31.66M-19.3% | -$26.55M-31.4% | -$20.21M-43.4% | ||
| —— | —— | $818K+7.1% | $764K+186% | $267K+521% | ||
| -$49.3M-18.2% | -$41.72M-26.6% | -$32.95M-16.1% | -$28.38M-23.0% | -$23.08M-32.4% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| -$49.3M-18.2% | -$41.72M-26.6% | -$32.95M-16.1% | -$28.38M-23.0% | -$23.08M-32.4% | ||
| -$4.17-12.4% | -$3.71-41.1% | -$2.63+52.5% | -$5.54+22.5% | -$7.15+10.1% | ||
| -$45.59M-18.1% | -$38.6M-21.9% | -$31.66M-19.3% | -$26.55M-31.4% | -$20.21M-43.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Palvella Therapeutics's income statement data come from?
- Every line is extracted from Palvella Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.